Pfizer vaccine meets criteria for success, FDA says

The Food and Drug Administration signaled Tuesday that it is likely to approve emergency use authorization for the Pfizer/BioNTech coronavirus vaccine.

In a detailed analysis released Tuesday morning, the FDA said that it could find “no specific safety concerns identified that would preclude issuance of an EUA.”

A majority did experience side effects commonly associated with vaccines, including fatigue, headaches, and pain at the injection site.

On Thursday, the FDA will hold a meeting of its Vaccines and Related Biological Products Advisory Committee, known as VRBPAC, to determine whether the...